FIVE BURROUGHS WELLCOME AZT PATENTS UPHELD ON APPEAL; SIXTH IS REMANDED TO LOWER COURT FOR FURTHER PROCEEDINGS: NOVOPHARM WILL PRESS ON WITH LITIGATION

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".